Abstract
Long noncoding RNAs (lncRNAs) are known to participate in the progression of several cancers, including esophageal carcinoma (EC), a common malignancy of the digestive system. Although the role of the lncRNA-miRNA-mRNA regulatory network is crucial for the growth and progression of EC, the regulation of lncRNA BBOX1-AS1 (BBOX1 antisense RNA1) remains unclear. We performed reverse transcription-quantitative PCR (RT-qPCR) and western blotting to evaluate miR-361-3p, collagen type V alpha 1 chain (COL5A1), and BBOX1-AS1 expression levels in EC cells and tissues. The colony formation assay (CFA) and Cell Counting Kit-8 (CCK-8) were employed to identify EC cell proliferation, while western blotting was used to examine EC cell apoptosis and Bax and Bcl-2 expression levels. The effect of BBOX1-AS1 on EC proliferation was determined using an in vivo carcinogenesis assay. Correlation between COL5A1, BBOX1-AS1, and miR-361-3p was examined using the luciferase reporter system and RNA immunoprecipitation assay (RIP). Herein, we observed that BBOX1-AS1 expression levels were upregulated in EC cells and tissues. BBOX1-AS1 knockdown inhibited EC cell proliferation and conferred a pro-apoptotic effect. These results indicated a positive interaction between BBOX1-AS1 and miR-361-3p in EC and a negative association with miR-361-3p. COL5A1 was recognized as a downstream miR-361-3p target and was inversely related to miR-361-3p in EC. Therefore, BBOX1-AS1 expression suppressed cell apoptosis and promoted cell proliferation via the downregulation of miR-361-3p and upregulation of COL5A1 expression. Overall, BBOX1-AS1 facilitates EC progression via the miR-361-3p or COL5A1 axis, indicating that BBOX1-AS1 might be a potential therapeutic target for EC therapy.
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed throughout this present investigation are available from the relevant author upon proper request.
References
Chan JJ, Tay Y (2018) Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci 19(5):1310
Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C, Zhang C (2016) MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. J Exp Clin Cancer Res 35:76
Chen SG, Wang CH, He RQ, Xu RY, Ji CB (2019) LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6. Eur Rev Med Pharmacol Sci 23:8878–8887
Chen Z, Lei T, Chen X, Gu J, Huang J, Lu B, Wang Z (2020) Long non-coding RNA in lung cancer clinica chimica acta international. J Clin Chem. https://doi.org/10.1016/j.cca.2019.11.031
Chu J, Li H, Xing Y, Jia J, Sheng J, Yang L, Sun K, Qu Y, Zhang Y, Yin H, Wan J, He F (2019) LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Biomed Pharmacother Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2019.109029
Feng Q, Zhang H, Yao D, Chen WD, Wang YD (2019) Emerging role of non-coding RNAs in esophageal squamous cell carcinoma. Int J Mol Sci 21(1):258
Gu J, Wang Y, Wu X (2013) MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des 19:1292–1300
He J, Huang B, Zhang K, Liu M, Xu T (2020) Long non-coding RNA in cervical cancer from biology to therapeutic opportunity. Biomed Pharmacother Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2020.110209
Huang FL, Yu SJ (2018) Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg 41:210–215
Iżykowska K, Rassek K, Korsak D, Przybylski GK (2020) Novel targeted therapies of T cell lymphomas. J Hematol Oncol 13:176
Jiang H, He Q, Liu T (2021) BBOX1-AS1 accelerates nasopharyngeal carcinoma progression by sponging miR-3940-3p and enhancing KPNA2 upregulation. Cancer Manage Res 13:9049–9062
Jin G, Yang Y, Tuo G, Wang W, Zhu Z (2020) LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498. Neoplasma 67:751–761
Kato H, Nakajima M (2013) Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg 61:330–335
Kitamura N, Sento S, Yoshizawa Y, Sasabe E, Kudo Y, Yamamoto T (2020) Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma. Int J Mol Sci 22(1):240
Lee YT, Tan YJ, Oon CE (2018) Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol 834:188–196
Li X, Zheng H (2020) LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis. Thoracic Cancer 11:295–304
Li JH, Liu S, Zhou H, Qu LH, Yang JH (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92-97
Lian YF, Jiang XM, Sui LH, Shi XJ (2021) Targeted regulation of BBOX1-AS1 on miR-361–3p and its effect on the biological function of non-small cell lung cancer cell. J Biol Regul Homeost Agents. https://doi.org/10.23812/21-143-l
Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang K, Guan X, Yang K, Bai Y (2018) LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death Differ 25:1980–1995
Liu W, Wei H, Gao Z, Chen G, Liu Y, Gao X, Bai G, He S, Liu T, Xu W, Yang X, Jiao J, Xiao J (2018) COL5A1 may contribute the metastasis of lung adenocarcinoma. Gene 665:57–66
Liu B, Sun Y, Tang M, Liang C, Huang CP, Niu Y, Wang Z, Chang C (2020) The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer. Cell Death Dis 11:807
Liu J, Zhu J, Xiao Z, Wang X, Luo J (2022) BBOX1-AS1 contributes to colorectal cancer progression by sponging hsa-miR-361-3p and targeting SH2B1. FEBS Open Bio 12:983–992
Meng L, Jia X, Yu W, Wang C, Chen J, Liu F (2020) Circular RNA UBAP2 contributes to tumor growth and metastasis of cervical cancer via modulating miR-361-3p/SOX4 axis. Cancer Cell Int 20:357
Mitamura T, Dong P, Ihira K, Kudo M, Watari H (2019) Molecular-targeted therapies and precision medicine for endometrial cancer. Jpn J Clin Oncol 49:108–120
Mitobe Y, Takayama KI, Horie-Inoue K, Inoue S (2018) Prostate cancer-associated lncRNAs. Cancer Lett 418:159–166
Nissen NI, Karsdal M, Willumsen N (2019) Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology. J Exp Clin Cancer Res 38:115
Olgun G, Sahin O, Tastan O (2018) Discovering lncRNA mediated sponge interactions in breast cancer molecular subtypes. BMC Genomics 19:650
Patel TH, Cecchini M (2020) Targeted therapies in advanced gastric cancer. Curr Treat Options Oncol 21:70
Piawah S, Venook AP (2019) Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer 125:4139–4147
Qi TF, Tang F, Yin J, Miao W, Wang Y (2022) Parallel-reaction monitoring revealed altered expression of a number of epitranscriptomic reader, writer, and eraser proteins accompanied with colorectal cancer metastasis. Proteomics. https://doi.org/10.1002/pmic.202200059
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108
Shi J, Yang C, An J, Hao D, Liu C, Liu J, Sun J, Jiang J (2021) KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway. J Exper Clin Cancer Res 40:148
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Wang T, Zhang XD, Hua KQ (2021) A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer. Taiwan J Obstet Gynecol 60:253–261
Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M (2020a) Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer 19:62
Wei Z, Chen L, Meng L, Han W, Huang L, Xu A (2020b) LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1. Gastric Cancer 23:1018–1032
Winkle M, El-Daly SM, Fabbri M, Calin GA (2021) Noncoding RNA therapeutics—challenges and potential solutions. Nat Rev Drug Discovery 20:629–651
Wu Y, Xu Y (2020) Integrated bioinformatics analysis of expression and gene regulation network of COL12A1 in colorectal cancer. Cancer Med 9:4743–4755
Wu M, Sun Q, Mo CH, Pang JS, Hou JY, Pang LL, Lu HP, Dang YW, Fang SJ, Tang D, Chen G, Feng ZB (2019) Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry. Oncol Rep 42:151–175
Wu B, Ren A, Tian Y, Huang R (2020) Hsa_circ_0075960 Serves as a Sponge for miR-361-3p/SH2B1 in endometrial carcinoma. Technol Cancer Res Treat. https://doi.org/10.1177/1533033820983079
Xia F, Chen Y, Jiang B, Bai N, Li X (2020) Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p. Cancer Cell Int 20:49
Xu J, Yang B, Wang L, Zhu Y, Zhu X, Xia Z, Zhao Z, Xu L (2020a) LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361–3p and HuR to drive cervical cancer progression cell. Proliferation 53(7):e12823
Xu J, Yang B, Wang L, Zhu Y, Zhu X, Xia Z, Zhao Z, Xu L (2020b) LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Cell Prolif 53:e12823
Yang YM, Hong P, Xu WW, He QY, Li B (2020) Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther 5:229
Yang Y, Yu Q, Li B, Guan R, Huang C, Yang X (2021) BBOX1-AS1 accelerates gastric cancer proliferation by sponging miR-3940-3p to upregulate BIRC5 expression. Dig Dis Sci 66:1054–1062
Yao H, Chen R, Yang Y, Jiang J (2021a) LncRNA BBOX1-AS1 aggravates the development of ovarian cancer by sequestering miR-361–3p to augment PODXL expression. Reprod Sci 28(3):736–744
Zhang C, Xie L, Fu Y, Yang J, Cui Y (2020) lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2. J Cell Physiol 235:7933–7944
Zhao B, Song X, Guan H (2020) CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis. Life Sci 244:117179
Zhou H, Tang H, Li N, Chen H, Chen X, Gu L, Zhang L, Tian G, Tao D (2020) MicroRNA-361-3p inhibit the progression of lymphoma by the Wnt/β-catenin signaling pathway. Cancer Manage Res 12:12375–12384
Acknowledgements
None.
Funding
The research obtained no financing at all.
Author information
Authors and Affiliations
Contributions
YHL conducted the experiments and data analysis. DSH conceived and designed this study. RDM formed the methodology. YL did investigation. HW authored the paper. This manuscript was reviewed and revised by YHL and DSH. This work has been reviewed and approved by all authors.
Corresponding authors
Ethics declarations
Competing Interests
The authors stated that they did not have any conflicts of interest.
Ethical Approval
The First Affiliated Hospital of Chengdu Medical College’s Ethics Committee approved this study (Chengdu, China). The World Medical Association’s Helsinki Declaration was followed in the conduct of this study. Informed consent papers were signed by each patient. The ethical committee of First Affiliated Hospital of Chengdu Medical College gave its approval to this study. The ARRIVE standards have been strictly followed in all of the animal investigations.
Consent for Publication
All participants approved publishing their names.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lu, YH., He, DS., Li, Y. et al. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis. Biochem Genet 61, 1351–1368 (2023). https://doi.org/10.1007/s10528-022-10307-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-022-10307-3